Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
Source:
Nasdaq GlobeNewswire
/
15 Oct 2024 07:00:00 America/Chicago
N/A
Share on,